Jun 16, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
New England Journal Of Medicine Publishes Results Of Two-Year Bloom Trial Showing Lor
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2247391" data-attributes="member: 124445"><p>Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai"), together with its U.S. subsidiary Eisai Inc. and Arena Pharmaceuticals, Inc. announced today that the results from the two-year BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial with lorcaserin will be published in the July 15, 2010, issue of the New England Journal of Medicine. Lorcaserin is a novel obesity and weight management drug. Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc. has granted Eisai Inc... <a href="http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/x5a9ly3BCMo" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/x5a9ly3BCMo/3GfH" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2247391, member: 124445"] Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai"), together with its U.S. subsidiary Eisai Inc. and Arena Pharmaceuticals, Inc. announced today that the results from the two-year BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial with lorcaserin will be published in the July 15, 2010, issue of the New England Journal of Medicine. Lorcaserin is a novel obesity and weight management drug. Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc. has granted Eisai Inc... [URL="http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/0/da"][IMG]http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/1/da"][IMG]http://feedads.g.doubleclick.net/~a/iaSuzACYM1sG5KMOTuypKQfiHPY/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/x5a9ly3BCMo[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/x5a9ly3BCMo/3GfH]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top